Advisory Committees

2019 Advisory Committee Tentative Meetings

The tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Changes to this list will be posted on this site on a quarterly basis with meetings occurring in the upcoming months.  FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2019.  You may also obtain up-to-date information by calling the Advisory Committee Information Line 1-800-741-8138 (301-443-0572 in the Washington, DC area).

 

Committee Name Tentative Date(s)of Meeting(s)
OFFICE OF THE COMMISSIONER
Pediatric Advisory Committee April 8, 2019, Sep 26 and 27, 2019
Science Board to the Food and Drug Administration Date(s), if needed, to be determined
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory Committee Date(s), if needed, to be determined
Blood Products Advisory Committee March 20-21, 2019
Cellular, Tissue and Gene Therapies Advisory Committee Date(s), if needed, to be determined
Vaccines and Related Biological Products Advisory Committee March 6-7, 2019
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Analgesic Drug Products Advisory Committee Date(s), if needed, to be determined
Antimicrobial Drugs Advisory Committee Date(s), if needed, to be determined
Arthritis Advisory Committee Date(s), if needed, to be determined
Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs) Date(s), if needed, to be determined
Cardiovascular and Renal Drugs Advisory Committee Date(s), if needed, to be determined
Dermatologic and Ophthalmic Drugs Advisory Committee Date(s), if needed, to be determined
Drug Safety and Risk Management Advisory Committee Date(s), if needed, to be determined
Endocrinologic and Metabolic Drugs Advisory Committee Date(s), if needed, to be determined
Gastrointestinal Drugs Advisory Committee Date(s), if needed, to be determined
Medical Imaging Drugs Advisory Committee Date(s), if needed, to be determined
Nonprescription Drugs Advisory Committee Date(s), if needed, to be determined
Oncologic Drugs Advisory Committee Date(s), if needed, to be determined
Peripheral and Central Nervous System Drugs Advisory Committee Date(s), if needed, to be determined
Advisory Committee for Pharmaceutical Science and Clinical Pharmacology Date(s), if needed, to be determined
Pharmacy Compounding Advisory Committee Date(s), if needed, to be determined
Psychopharmacologic Drugs Advisory Committee Date(s), if needed, to be determined
Pulmonary-Allergy Drugs Advisory Committee Date(s), if needed, to be determined
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Medical Devices Advisory Committee (Comprised of 18 Panels)
Circulatory System Devices Panel Date(s), if needed, to be determined
Obstetrics and Gynecology Devices Panel February 12, 2019
Microbiology Devices Panel March 8, 2019
General and Plastic Surgery Devices Panel March 25-26, 2019
Neurological Devices Panel March 21, 2019
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)
Science Advisory Board to NCTR Date(s), if needed, to be determined
CENTER FOR TOBACCO PRODUCTS
Tobacco Products Scientific Advisory Committee February 6-7, 2019

 

Page Last Updated: 02/04/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English